Daffodil
Senior Member
- Messages
- 5,894
with regular infusions, you would have no B cells!
it gets rid of B cells. some of them are autoreactive..ie attacking the body
are the people who are giving rituximab giving antivirals right after it?
heap..since you are doing better on antivirals, you might do very well on rituximab if followed by antivirals to prevent reinfection of more B cells with EBV
but I don't know....my brain is mush
it gets rid of B cells. some of them are autoreactive..ie attacking the body
are the people who are giving rituximab giving antivirals right after it?
heap..since you are doing better on antivirals, you might do very well on rituximab if followed by antivirals to prevent reinfection of more B cells with EBV
but I don't know....my brain is mush
Rituximab 500 mg/m2 (maximum 1000 mg), diluted in saline to a concentration of 2 mg/ml, or an equal volume of saline, were given twice two weeks apart, with nurse surveillance and according to local guidelines used for treating B-cell lymphomas. No additional Rituximab infusions, or other intervention, were given during follow-up.
thanks deleder.
gave myself 6th infusion of gamunex last night. just getting worse with each one lol
Is Ampligen for sale, @heapsreal ?
No. At least not Rituximab. It is cost effective. Think of all the people that can get off disability schemes.
I agree for people getting of disability but i dont think alot of politicians can see that far ahead unfortunately.
If say, 70%, of patients treated with Rituximab can get back to work, politicians will get it. With a estimated 1 million M.E sufferers in the U.S, this could be what the U.S need to finally get out of their deficit lol. Remember that Rituximab is used to treat rheumatoid arthritis and other autoimmune diseases.
The patent is expired in Europe, and expires in the U.S in a few years. Prices will plummet.